Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Salagre

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of the Association of Physicians of India|October 14, 2016
Prevalence and Clinical Profile of Metabolic Syndrome in Hypertensive SubjectsS B Salagre, S M Itolikar, J J Churiwala
The Journal of the Association of Physicians of India|September 27, 2016
Extreme ThrombocytosisS M Itolikar, S B Salagre, S Yadav, et al.
European Journal of Medical Research|August 8, 2009
Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in indian patients with mild-to-moderate essential hypertensionA Pareek, S D Zawar, S B Salagre, et al.
Current Medical Research and Opinion|May 16, 2008
Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled studyA Pareek, N Karnik, S B Salagre, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of the Association of Physicians of India|October 14, 2016
Prevalence and Clinical Profile of Metabolic Syndrome in Hypertensive SubjectsS B Salagre, S M Itolikar, J J Churiwala
The Journal of the Association of Physicians of India|September 27, 2016
Extreme ThrombocytosisS M Itolikar, S B Salagre, S Yadav, et al.
European Journal of Medical Research|August 8, 2009
Antihypertensive efficacy of metoprolol XL/low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in indian patients with mild-to-moderate essential hypertensionA Pareek, S D Zawar, S B Salagre, et al.
Current Medical Research and Opinion|May 16, 2008
Clinical effectiveness of low-dose chlorthalidone (6.25 mg) + atenolol combination in stage I hypertensive patients: a multicenter, randomized, controlled studyA Pareek, N Karnik, S B Salagre, et al.
Pageof 1